| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-2236(96)10060-6 |
| P698 | PubMed publication ID | 8931276 |
| P2093 | author name string | Wood MJ | |
| Kajiwara K | |||
| Wood KJ | |||
| Charlton HM | |||
| Byrnes AP | |||
| P2860 | cites work | An Essential Role for Type 1 Interferon-γ in Terminating Persistent Viral Infection | Q58828960 |
| Transfer of a foreign gene into the brain using adenovirus vectors | Q64377820 | ||
| Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies | Q64383045 | ||
| Adenovirus gene transfer causes inflammation in the brain | Q64383186 | ||
| Adenovirus entry into host cells: a role for alpha(v) integrins | Q64383600 | ||
| T-lymphocyte entry into the central nervous system | Q70156307 | ||
| Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats | Q72153719 | ||
| Gene therapy for neurological disorders | Q72157283 | ||
| Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin | Q72244649 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
| Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo | Q34040679 | ||
| Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer | Q34926866 | ||
| Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction | Q35051812 | ||
| Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy | Q35232341 | ||
| Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses | Q35837026 | ||
| Induction of MHC class I genes in neurons | Q36688665 | ||
| The immune response to intracerebral neural grafts | Q36705265 | ||
| A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia | Q37412249 | ||
| Macrophages and inflammation in the central nervous system | Q40489629 | ||
| Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. | Q40668189 | ||
| The principles of gene therapy for the nervous system | Q41120773 | ||
| Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants | Q41263288 | ||
| Pulmonary inflammation induced by incomplete or inactivated adenoviral particles | Q41263315 | ||
| Neuronal cells are deficient in loading peptides onto MHC class I molecules | Q41620648 | ||
| MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. | Q41664847 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. | Q43535009 | ||
| Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer | Q44747875 | ||
| Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination | Q44907561 | ||
| The production of focal herpes encephalitis in mice by stereotaxic inoculation of virus. Anatomical and behavioral effects | Q45836737 | ||
| Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration | Q45866667 | ||
| An adenovirus vector for gene transfer into neurons and glia in the brain | Q45874317 | ||
| Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors | Q45875094 | ||
| Adenoviral vectors as functional retrograde neuronal tracers | Q48106092 | ||
| The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents | Q48278859 | ||
| A model system for in vivo gene transfer into the central nervous system using an adenoviral vector | Q48325479 | ||
| Specific Patterns of Defective HSV-1 Gene Transfer in the Adult Central Nervous System: Implications for Gene Targeting | Q58822234 | ||
| P433 | issue | 11 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 497-501 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Trends in Neurosciences | Q3538443 |
| P1476 | title | Immune responses to adenovirus vectors in the nervous system | |
| P478 | volume | 19 |
| Q41058416 | A gamma34.5 mutant of herpes simplex 1 causes severe inflammation in the brain. |
| Q48486087 | APOE epsilon3 gene transfer attenuates brain damage after experimental stroke |
| Q44684310 | Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes |
| Q44082453 | Adenoviral gene transfer of aspartoacylase into the tremor rat, a genetic model of epilepsy, as a trial of gene therapy for inherited epileptic disorder. |
| Q45887941 | Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration |
| Q41068462 | Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease |
| Q45861869 | Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences |
| Q45855527 | Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways |
| Q35575249 | Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease |
| Q48594392 | Application of recombinant adenovirus for in vivo gene delivery to spinal cord |
| Q36842495 | Blood-brain barrier transport of non-viral gene and RNAi therapeutics |
| Q31013320 | Combining cytotoxic and immune-mediated gene therapy to treat brain tumors |
| Q92539077 | Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management |
| Q64381079 | Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats |
| Q45736046 | Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector |
| Q47318878 | Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients |
| Q34152190 | Future directions in alcoholism research. Genomics and gene transfer. |
| Q33917592 | Gene delivery with viral vectors for cerebrovascular diseases |
| Q46173833 | Gene targeting in vivo with pegylated immunoliposomes |
| Q34119431 | Gene transfer for cerebrovascular disease |
| Q33904294 | Gene transfer into rat brain using adenoviral vectors. |
| Q45747744 | Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors |
| Q40604183 | Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. |
| Q45884040 | High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain |
| Q42861412 | Immune regulation of transgene expression in the brain: B cells regulate an early phase of elimination of transgene expression from adenoviral vectors |
| Q36274402 | Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells. |
| Q34500928 | Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective |
| Q33841658 | In situ use of suicide genes for therapy of brain tumours |
| Q33216908 | In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system. |
| Q35131222 | Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences |
| Q45861874 | Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus |
| Q42536199 | Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. |
| Q31923956 | Intravitreal adenoviral gene transfer evokes an immune response in the retina that is directed against the heterologous lacZ transgene product but does not limit transgene expression |
| Q45877189 | Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS. |
| Q45890414 | Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis. |
| Q35734505 | Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. |
| Q35563389 | Molecular biology and gene therapy in the treatment of chronic pain. |
| Q40630598 | Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury |
| Q35163431 | Noninvasive gene targeting to the brain |
| Q33985663 | Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders |
| Q35161530 | Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for ch |
| Q34757639 | Preferential and bidirectional labeling of the rubrospinal tract with adenovirus-GFP for monitoring normal and injured axons. |
| Q36014895 | Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells |
| Q64381948 | Promoter-independent regulation of cell-specific dopamine receptor expression |
| Q40633580 | Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease |
| Q48515148 | Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain |
| Q34361466 | Regulatable and cell-type specific transgene expression in glial cells: prospects for gene therapy for neurological disorders |
| Q39988205 | Reversal of mdr1b-dependent multidrug resistance in a rat astrocyte model by adenoviral-delivered short hairpin RNA. |
| Q45360347 | Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer's disease |
| Q33713348 | Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented. |
| Q48348307 | Suppression of inflammation by dexamethasone prolongs adenoviral vector-mediated transgene expression in the facial nucleus of the rat. |
| Q44612690 | Targeting conditional gene modification into the serotonin neurons of the dorsal raphe nucleus by viral delivery of the Cre recombinase |
| Q35585191 | The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier |
| Q41102311 | The coming of age of the GDNF family and its receptors: gene delivery in a rat Parkinson model may have clinical implications |
| Q37485007 | The therapeutic potential of interleukin-10 in neuroimmune diseases. |
| Q35203194 | Therapeutic gene silencing in the nervous system |
| Q34105795 | Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model |
| Q35576698 | Translational Paradigms in Cerebrovascular Gene Transfer |
| Q36249210 | Treatment of Parkinson's disease : what's on the horizon? |
| Q45862071 | Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming |
| Q35618384 | Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. |
| Q36960666 | Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production. |
Search more.